Study of fatty liver in people born with low birth weight
Part of Digestive system, Hormones & metabolism clinical trials.
This trial focuses on people who have fatty liver disease (extra fat in the liver) and were born with low birth weight. It aims to test an approach in this specific group, which may help clarify what helps the liver in higher-risk people.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have fatty liver disease confirmed by a liver-fat scan (MRS) showing at least 5% liver fat
- Your body mass index (BMI) is between 18.5 and 30
- You do not have a strong family history of diabetes in close family members
- You do not take medications or have illnesses known to strongly affect the study results
- Your alcohol intake is not above general recommended limits
- Your weight hasn’t changed by more than 3 kg in the last 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses multiple types of health data (“multi-omics”) to help choose a personalized treatment plan for people with obesity-related fatty liver disease. It may help match treatment to your biology to improve outcomes.
This trial tests whether a very low calorie ketogenic diet (a strict low-carb, high-fat diet) can help people with non-alcoholic steatohepatitis (NASH) who have liver scarring. Participants will follow this diet for a year and have two liver biopsies to see if their liver health improves.
This study looks at people with fatty liver disease and common health issues like obesity, diabetes, high blood pressure, or abnormal cholesterol. It may help researchers understand how liver fat and heart/metabolism problems relate and how they affect health over time.
This study follows adults with nonalcohol-related fatty liver disease (NAFLD) to better understand the condition and what factors affect it. It may help researchers learn which patients are most at risk and how care can be improved in the future.
This study collects blood samples from donors with excess weight or related health issues to better understand fatty liver disease. If you are a blood donor between 40 and 65, and have overweight, high blood sugar, abnormal cholesterol, or high blood pressure, you may be able to help.
This study tests whether intermittent fasting combined with a Mediterranean diet can help people with moderate to severe non-alcoholic fatty liver disease (NAFLD) improve their liver health. If you are overweight and have been diagnosed with NAFLD, this trial may offer a dietary approach to manage your condition.
Hear when a new NAFLD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.